Zurück

Lungenschonende Beatmungsmethoden für die Ein-Lungen-Ventilation

Artikel

Autor: Munir Karjaghli, klinischer Anwendungsspezialist, Hamilton Medical AG

Datum: 15.11.2021

Das akute Atemnotsyndrom (ARDS) oder eine akute Lungenschädigung (ALI) sind häufig lebensbedrohliche Komplikationen nach einer grösseren Lungenresektion. In grossen Kohortenstudien traten bei 2 bis 4 % der Studienteilnehmer (1-3) nach einer grösseren Lungenresektion ARDS oder ALI auf. Wenn diese Komplikationen auftreten, sind sie mit einer Sterblichkeitsrate von 50 bis 70 % verbunden (1-3).
Lungenschonende Beatmungsmethoden für die Ein-Lungen-Ventilation

Kernaussagen

  • Das akute Atemnotsyndrom (ARDS) oder eine akute Lungenschädigung (ALI) sind häufig lebensbedrohliche Komplikationen nach einer grösseren Lungenresektion.
  • Die Ein-Lungen-Ventilation (ELV) während und nach einer Thorax-OP erhöht das Risiko für Volutrauma, Barotrauma, Atelektrauma und Sauerstofftoxikose.
  • Die Anwendung eines lungenschonenden Beatmungsprotokolls während der ELV, das permissive Hyperkapnie, niedrige Tidalvolumina, einen erhöhten positiven endexspiratorischen Druck, die Begrenzung des durch das Beatmungsgerät verabreichten Drucks und Recruitmentmanöver umfasst, kann das Risiko für eine akute Lungenschädigung verringern.

Ursachen für eine Lungenschädigung

Die maschinelle Beatmung während der Ein-Lungen-Ventilation (ELV), die auch als Ein-Lungen-Beatmung bezeichnet wird, hat drei Ziele: Sie soll (I) die Eliminierung von Kohlendioxid unterstützen, (II) die Oxygenierung aufrechterhalten und (III) die postoperative Lungendysfunktion reduzieren. Es wurden zahlreiche Studien durchgeführt, um die geeignetste Strategie für die maschinelle Beatmung während der ELV zu ermitteln. 

Viele unterschiedliche Faktoren können zu einer perioperativen akuten Lungenschädigung (ALI) beitragen. Lungenschädigungen sind auf mechanische Beanspruchungen durch Hyperinflation, Hyperperfusion und zyklisches Recruitment/Derecruitment in Kombination mit proinflammatorischen oder biochemischen Faktoren zurückzuführen. Bei Patienten, die sich einer Thorax-OP unterziehen, geht eine „Multiple-hit“-Theorie davon aus, dass eine Kombination aus OP-bezogenen Faktoren, Ein-Lungen-Ventilation, zugrunde liegenden Krankheiten und Begleiterkrankungen, vorheriger Therapie und anderen nicht bekannten Ereignissen die Wahrscheinlichkeit für eine ALI erhöhen kann (Lytle FT, Brown DR. Appropriate ventilatory settings for thoracic surgery: intraoperative and postoperative. Semin Cardiothorac Vasc Anesth. 2008;12(2):97-108. doi:10.1177/10892532083198694​).

Die Ein-Lungen-Ventilation während und nach einer Thorax-OP erhöht das Risiko für Volutrauma, Barotrauma, Atelektrauma und Sauerstofftoxikose. Das sind alles schwerwiegende Komplikationen, die eine beatmungsinduzierte Lungenschädigung zur Folge haben können (Lohser J. Evidence-based management of one-lung ventilation. Anesthesiol Clin. 2008;26(2):241-v. doi:10.1016/j.anclin.2008.01.0115​).

Was macht die lungenschonende Ein-Lungen-Ventilation aus?

Es gibt sehr wenige Daten, die im Hinblick auf die klinischen Ergebnisse speziell für einen bestimmten Managementansatz für die ELV sprechen. Die Definition, was als lungenschonende ELV anzusehen ist, wird hauptsächlich von der Expertenmeinung, Daten zur Zwei-Lungen-Ventilation bei allgemeinchirurgischen Patienten und einer kleinen Anzahl klinischer Studien beeinflusst. Beispielsweise ist es sehr schwierig, das Tidalvolumen als einzelnen Faktor zu identifizieren, der während der ELV zu einer Lungenschädigung beiträgt. Bisher konnte keine Studie definitiv den besonderen Vorteil einer Beatmung mit niedrigem Tidalvolumen (Vt) während der ELV belegen, wenn keine anderen Beatmungsstrategien wie ein positiver endexspiratorischer Druck (PEEP) (Blank RS, Colquhoun DA, Durieux ME, et al. Management of One-lung Ventilation: Impact of Tidal Volume on Complications after Thoracic Surgery. Anesthesiology. 2016;124(6):1286-1295. doi:10.1097/ALN.00000000000011006​), die Begrenzung des Atemwegsdrucks und Recruitmentmanöver zum Einsatz kommen. Sofern keine Kontraindikation besteht, können diese Beatmungsmethoden bei allen Patienten, die sich einer Thorax-OP unterziehen, sowohl während als auch nach dem Eingriff angewendet werden. Recruitment und PEEP tragen zusammen mit Flüssigkeiten, Entzündungen, Anästhetika und anderen unbekannten Variablen zu einer lungenschonenden Beatmung bei (Slinger PD. Do Low Tidal Volumes Decrease Lung Injury During One-Lung Ventilation?. J Cardiothorac Vasc Anesth. 2017;31(5):1774-1775. doi:10.1053/j.jvca.2017.07.0057​). Ohne angemessenen PEEP kann ein niedriges Vt während der ELV zu Atelektase führen und damit das Sterblichkeitsrisiko erhöhen (Levin MA, McCormick PJ, Lin HM, Hosseinian L, Fischer GW. Low intraoperative tidal volume ventilation with minimal PEEP is associated with increased mortality. Br J Anaesth. 2014;113(1):97-108. doi:10.1093/bja/aeu0548​). Ein niedriger PEEP reicht möglicherweise nicht aus, um die Alveolen zu stabilisieren, die Dehnungsbelastung der Alveolen zu reduzieren und bei Patienten eine Atelektase zu verhindern. Atelektase ist bei allen anästhesierten Chirurgiepatienten ein Problem. Während der ELV ist sie jedoch möglicherweise durch den Einsatz höherer inspiratorischer Sauerstofffraktionen (Resorptionsatelektase) und das erhöhte Risiko einer Kompression der abhängigen Lunge (Kompressionsatelektase) gravierender (Duggan M, Kavanagh BP. Pulmonary atelectasis: a pathogenic perioperative entity. Anesthesiology. 2005;102(4):838-854. doi:10.1097/00000542-200504000-000219​).

Ist der Driving Pressure wichtiger als das Tidalvolumen?

Bei einer retrospektiven Studie, die nach der Umsetzung eines Protokolls für die lungenschonende Beatmung während der ELV bei Lungenkrebs-OPs durchgeführt wurde, das ein reduziertes Vt, einen erhöhten PEEP, die Begrenzung des durch das Beatmungsgerät verabreichten Drucks und Recruitmentmanöver umfasst, wurde eine niedrigeres Risiko für eine akute Lungenschädigung festgestellt (Licker M, Diaper J, Villiger Y, et al. Impact of intraoperative lung-protective interventions in patients undergoing lung cancer surgery. Crit Care. 2009;13(2):R41. doi:10.1186/cc776210​). Die genaue Auswirkung des Vt ist zwar nicht bekannt, aber neue Studienergebnisse legen nahe, dass sich der Driving Pressure (und nicht das Vt oder der PEEP) als potenzieller Indikator für die Prognose des postoperativen Risikos von Lungenkomplikationen eignet. Ausserdem wurde die Anwendung einer am Driving Pressure orientierten Beatmung während der ELV im Vergleich zur konventionellen lungenschonenden Beatmung bei Lungen-OPs mit einem selteneren Auftreten von postoperativen Lungenkomplikationen in Verbindung gebracht (Park M, Ahn HJ, Kim JA, et al. Driving Pressure during Thoracic Surgery: A Randomized Clinical Trial. Anesthesiology. 2019;130(3):385-393. doi:10.1097/ALN.000000000000260011​).

Praxisrichtlinien für das maschinelle Beatmungsmanagement während der ELV

Die Society for Translational Medicine hat auf Grundlage der aktuellen Studienergebnisse zur Ein-Lungen-Ventilation Empfehlungen in ihre Richtlinien für die klinische Praxis zum maschinellen Beatmungsmanagement bei Patienten aufgenommen, die sich einer Lobektomie unterziehen (Gao S, Zhang Z, Brunelli A, et al. The Society for Translational Medicine: clinical practice guidelines for mechanical ventilation management for patients undergoing lobectomy. J Thorac Dis. 2017;9(9):3246-3254. doi:10.21037/jtd.2017.08.16612​).

  • Permissive/therapeutische Hyperkapnie zur Erhaltung eines Kohlendioxid-Partialdrucks von 50 bis 70 mmHg kann sich bei Patienten positiv auswirken, die während Lobektomie-Eingriffen an der Lunge mit Ein-Lungen-Ventilation beatmet werden.
  • Die lungenschonende Beatmung mit einem Tidalvolumen von 4 bis 6 ml/kg und einem PEEP von 5 bis 8 cmH2O und gleichzeitiger Aufrechterhaltung eines Driving Pressure von < 15 cmH2O scheint auf Grundlage der aktuellen Studienergebnisse sinnvoll zu sein.
  • Ein Recruitment der Alveolen (Open-Lung-Beatmung) kann bei Patienten vorteilhaft sein, die sich einer Lobektomie mit Ein-Lungen-Ventilation unterziehen.
  • Eine reine druckkontrollierte Beatmung (CMV-PC) oder eine druckkontrollierte Beatmung mit Volumengarantie (CMV-vtPC) ist gegenüber einer volumenkontrollierten Beatmung (CMV-VC) zu bevorzugen und kann bei Patienten angewendet werden, bei denen eine Lungenresektion mit Ein-Lungen-Ventilation durchgeführt wird.
  • Es ist sinnvoll, die niedrigste FiO2-Konzentration anzuwenden, die für die Erhaltung einer zufriedenstellenden arteriellen Sauerstoffsättigung nötig ist.
  • Die kontrollierte maschinelle Beatmung mit einem I:E-Verhältnis von 1:1 oder höher ist bei Patienten angebracht, die mit Ein-Lungen-Ventilation beatmet werden.

Der Modus ASV® (Adapative Support Ventilation®) wendet auf allen Beatmungsgeräten von Hamilton Medical eine lungenschonende Strategie an, die den Empfehlungen für das Tidalvolumen und den Driving Pressure bei der ELV entspricht. Ausserdem bietet Ihnen der vollständig rückgekoppelte Closed-Loop-Modus INTELLiVENT®-ASV (Nicht in den USA und für einige andere Märkte verfügbar.A​) die Möglichkeit, automatisch permissive Hyperkapnie umzusetzen und die niedrigste FiO2-Konzentration zu verabreichen, die für die Erhaltung einer zufriedenstellenden arteriellen Sauerstoffsättigung nötig ist.

Eine Studie von Weiler et al. zeigt, dass Patienten mit dem Modus ASV sogar unter den hoch variablen Bedingungen der ELV sicher beatmet werden können (Weiler N, Eberle B, Heinrichs W. Adaptive lung ventilation (ALV) during anesthesia for pulmonary surgery: automatic response to transitions to and from one-lung ventilation. J Clin Monit Comput. 1998;14(4):245-252. doi:10.1023/a:100997482523713​).

Die Abbildungen 1 und 2 unten zeigen einen 61 Jahre alten Patienten, der während einer Pneumonektomie am rechten Lungenflügel mit ASV beatmet wurde.


Den vollständigen Quellenverweis finden Sie unten: (Ruffini E, Parola A, Papalia E, et al. Frequency and mortality of acute lung injury and acute respiratory distress syndrome after pulmonary resection for bronchogenic carcinoma. Eur J Cardiothorac Surg. 2001;20(1):30-37. doi:10.1016/s1010-7940(01)00760-61​, Kutlu CA, Williams EA, Evans TW, Pastorino U, Goldstraw P. Acute lung injury and acute respiratory distress syndrome after pulmonary resection. Ann Thorac Surg. 2000;69(2):376-380. doi:10.1016/s0003-4975(99)01090-52​, Shapiro M, Swanson SJ, Wright CD, et al. Predictors of major morbidity and mortality after pneumonectomy utilizing the Society for Thoracic Surgeons General Thoracic Surgery Database. Ann Thorac Surg. 2010;90(3):927-935. doi:10.1016/j.athoracsur.2010.05.0413​) 

Display mit Grafik „Dynam.Lunge“ und ASV-Grafik
Abbildung 1
Display mit Grafik „Dynam.Lunge“ und ASV-Grafik
Abbildung 1
Display mit allen Monitoring-Parametern
Abbildung 2
Display mit allen Monitoring-Parametern
Abbildung 2

Fußnoten

  • A. Nicht in den USA und für einige andere Märkte verfügbar.

Referenzen

  1. 1. Ruffini E, Parola A, Papalia E, et al. Frequency and mortality of acute lung injury and acute respiratory distress syndrome after pulmonary resection for bronchogenic carcinoma. Eur J Cardiothorac Surg. 2001;20(1):30-37. doi:10.1016/s1010-7940(01)00760-6
  2. 2. Kutlu CA, Williams EA, Evans TW, Pastorino U, Goldstraw P. Acute lung injury and acute respiratory distress syndrome after pulmonary resection. Ann Thorac Surg. 2000;69(2):376-380. doi:10.1016/s0003-4975(99)01090-5
  3. 3. Shapiro M, Swanson SJ, Wright CD, et al. Predictors of major morbidity and mortality after pneumonectomy utilizing the Society for Thoracic Surgeons General Thoracic Surgery Database. Ann Thorac Surg. 2010;90(3):927-935. doi:10.1016/j.athoracsur.2010.05.041
  4. 4. Lytle FT, Brown DR. Appropriate ventilatory settings for thoracic surgery: intraoperative and postoperative. Semin Cardiothorac Vasc Anesth. 2008;12(2):97-108. doi:10.1177/1089253208319869
  5. 5. Lohser J. Evidence-based management of one-lung ventilation. Anesthesiol Clin. 2008;26(2):241-v. doi:10.1016/j.anclin.2008.01.011
  6. 6. Blank RS, Colquhoun DA, Durieux ME, et al. Management of One-lung Ventilation: Impact of Tidal Volume on Complications after Thoracic Surgery. Anesthesiology. 2016;124(6):1286-1295. doi:10.1097/ALN.0000000000001100
  7. 7. Slinger PD. Do Low Tidal Volumes Decrease Lung Injury During One-Lung Ventilation?. J Cardiothorac Vasc Anesth. 2017;31(5):1774-1775. doi:10.1053/j.jvca.2017.07.005
  8. 8. Levin MA, McCormick PJ, Lin HM, Hosseinian L, Fischer GW. Low intraoperative tidal volume ventilation with minimal PEEP is associated with increased mortality. Br J Anaesth. 2014;113(1):97-108. doi:10.1093/bja/aeu054
  9. 9. Duggan M, Kavanagh BP. Pulmonary atelectasis: a pathogenic perioperative entity. Anesthesiology. 2005;102(4):838-854. doi:10.1097/00000542-200504000-00021
  10. 10. Licker M, Diaper J, Villiger Y, et al. Impact of intraoperative lung-protective interventions in patients undergoing lung cancer surgery. Crit Care. 2009;13(2):R41. doi:10.1186/cc7762
  11. 11. Park M, Ahn HJ, Kim JA, et al. Driving Pressure during Thoracic Surgery: A Randomized Clinical Trial. Anesthesiology. 2019;130(3):385-393. doi:10.1097/ALN.0000000000002600
  12. 12. Gao S, Zhang Z, Brunelli A, et al. The Society for Translational Medicine: clinical practice guidelines for mechanical ventilation management for patients undergoing lobectomy. J Thorac Dis. 2017;9(9):3246-3254. doi:10.21037/jtd.2017.08.166
  13. 13. Weiler N, Eberle B, Heinrichs W. Adaptive lung ventilation (ALV) during anesthesia for pulmonary surgery: automatic response to transitions to and from one-lung ventilation. J Clin Monit Comput. 1998;14(4):245-252. doi:10.1023/a:1009974825237

Frequency and mortality of acute lung injury and acute respiratory distress syndrome after pulmonary resection for bronchogenic carcinoma.

Ruffini E, Parola A, Papalia E, et al. Frequency and mortality of acute lung injury and acute respiratory distress syndrome after pulmonary resection for bronchogenic carcinoma. Eur J Cardiothorac Surg. 2001;20(1):30-37. doi:10.1016/s1010-7940(01)00760-6



OBJECTIVE

We reviewed the frequency and mortality of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) in our population of patients submitted to pulmonary resection for primary bronchogenic carcinoma.

METHODS

From January 1993 to December 1999, a total of 1221 patients received pulmonary resection for primary bronchogenic carcinoma. Of these, 27 met the criteria of post-operative ALI/ARDS. There were 24 men and three women with a mean age of 64 years (range 45--79). Pre-operatively, predicted mean of PaO(2), PaCO(2) and %FEV1 were 72 mmHg (57--86), 37 mmHg (33--42) and 80% (37--114), respectively. Associated cardiac risk factors were present in eight patients. Three patients (11%) had pre-operative radiotherapy. Surgical-pathologic staging included 14 patients at Stage I, 8 patients at Stage II, four patients at Stage IIIa and one patient at Stage IIIb.

RESULTS

ALI/ARDS occurred in 2.2% of our operated lung cancer patients. ALI was diagnosed in 10 patients and ARDS in 17 patients. The mean time of presentation following surgery was 4 days (range 1--10) and 6 days (1--13) for ALI and ARDS, respectively. According to the type of operation, the frequency was highest following right pneumonectomy (4.5%), followed by sublobar resection (3.2%), left pneumonectomy (3%), bilobectomy (2.4%), and lobectomy (2%). The frequency following extended operations was 4%. No differences were found between the ALI/ARDS group and the total population of resected lung cancer patients (control group) with respect to sex, mean age, pre-operative blood gases, %FEV1, surgical--pathologic staging and the use of pre-operative radiotherapy. Four patients with ALI (40%) and 10 patients with ARDS (59%) died. Mortality was highest following right pneumonectomy, extended operations and sublobar resections. Hospital mortality of the total population of operated lung cancer patients in the same period was 2.8% (34 patients). ALI/ARDS accounted for 41% of our hospital mortality.

CONCLUSIONS

(1) ALI/ARDS is a severe complication following resection for primary bronchogenic carcinoma. (2) We did not detect any significant difference between the ALI/ARDS group and the control group regarding age, pre-operative lung function, staging and pre-operative radiotherapy. (3) ALI/ARDS is associated with high mortality, the highest mortality rates having been observed following right pneumonectomy and extended operation; it currently represents our leading cause of death following pulmonary resection for lung carcinoma. (4) ALI/ARDS may also occur after sublobar resections with an associated high mortality rate.

Acute lung injury and acute respiratory distress syndrome after pulmonary resection.

Kutlu CA, Williams EA, Evans TW, Pastorino U, Goldstraw P. Acute lung injury and acute respiratory distress syndrome after pulmonary resection. Ann Thorac Surg. 2000;69(2):376-380. doi:10.1016/s0003-4975(99)01090-5



BACKGROUND

In this study we investigate the frequency and mortality of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) after pulmonary resection.

METHODS

Patients that underwent pulmonary resection at the Royal Brompton Hospital between 1991 and 1997 were included. The case notes of all patients developing postoperative complications were retrospectively reviewed.

RESULTS

The overall combined frequency of ALI and ARDS was 3.9%. The frequency was higher in patients over 60 years of age, males and those undergoing resection for lung cancer. ALI/ARDS caused 72.5% of the total mortality after resection in this series.

CONCLUSIONS

In our experience ALI and ARDS are major causes of mortality after lung resection.

Predictors of major morbidity and mortality after pneumonectomy utilizing the Society for Thoracic Surgeons General Thoracic Surgery Database.

Shapiro M, Swanson SJ, Wright CD, et al. Predictors of major morbidity and mortality after pneumonectomy utilizing the Society for Thoracic Surgeons General Thoracic Surgery Database. Ann Thorac Surg. 2010;90(3):927-935. doi:10.1016/j.athoracsur.2010.05.041



BACKGROUND

Pneumonectomy is associated with a significant incidence of perioperative morbidity and mortality. The purpose of this study is to identify the risk factors responsible for adverse outcomes in patients after pneumonectomy utilizing The Society of Thoracic Surgeons General Thoracic Surgery Database (STS GTDB).

METHODS

All patients who had undergone pneumonectomy between January 2002 and December 2007 were identified in the STS GTDB. Among 80 participating centers, 1,267 patients were selected. Logistic regression analysis was performed on preoperative variables for major adverse outcomes.

RESULTS

The rate of major adverse perioperative events was 30.4%, including 71 patients who died (5.6%). Major morbidity was defined as pneumonia, adult respiratory distress syndrome, empyema, sepsis, bronchopleural fistula, pulmonary embolism, ventilatory support beyond 48 hours, reintubation, tracheostomy, atrial or ventricular arrhythmias requiring treatment, myocardial infarct, reoperation for bleeding, and central neurologic event. Patients with major morbidity had a longer mean length of stay compared with patients without major morbidity (13.3 versus 6.1 days, p < 0.001). Independent predictors of major adverse outcomes were age 65 years or older (p < 0.001), male sex (p = 0.026), congestive heart failure (p = 0.04), forced expiratory volume in 1 second less than 60% of predicted (p = 0.01), benign lung disease (p = 0.006), and requiring extrapleural pneumonectomy (p = 0.018). Among patients with lung carcinoma, those receiving neoadjuvant chemoradiotherapy were more at risk for major morbidity than patients without induction therapy (p = 0.049).

CONCLUSIONS

The mortality rate after pneumonectomy by thoracic surgeons participating in the STS database compares favorably to that in previously published studies. We identified risk factors for major adverse outcomes in patients undergoing pneumonectomy.

Appropriate ventilatory settings for thoracic surgery: intraoperative and postoperative.

Lytle FT, Brown DR. Appropriate ventilatory settings for thoracic surgery: intraoperative and postoperative. Semin Cardiothorac Vasc Anesth. 2008;12(2):97-108. doi:10.1177/1089253208319869

Mechanical ventilation of patients undergoing thoracic surgery is often challenging. These patients frequently have significant underlying comorbidities, including cardiopulmonary disease, and often must undergo 1-lung ventilation. Perioperative respiratory complications are common and are multifactorial in etiology. Increasing evidence suggests that mechanical ventilation is associated with, and may even cause, lung damage in both sick and healthy patients. Gas exchange to provide acceptable end-organ oxygenation remains a primary goal but so too is minimization of risks for acute lung injury. Every ventilator strategy is associated with potential beneficial and adverse side effects. Understanding the impact of various ventilation strategies allows clinicians to provide optimal care for patients.

Evidence-based management of one-lung ventilation.

Lohser J. Evidence-based management of one-lung ventilation. Anesthesiol Clin. 2008;26(2):241-v. doi:10.1016/j.anclin.2008.01.011

One-lung ventilation (OLV) is essential for many thoracic and an increasing number of non-thoracic minimally invasive procedures. Beyond the well-recognized disturbance of ventilation-perfusion matching, recent years have seen a mounting body of evidence implicating OLV in the creation of acute lung injury. After reviewing the fundamentals of OLV physiology, this article examines the evidence for altering individual ventilatory parameters toward protective OLV.

Management of One-lung Ventilation: Impact of Tidal Volume on Complications after Thoracic Surgery.

Blank RS, Colquhoun DA, Durieux ME, et al. Management of One-lung Ventilation: Impact of Tidal Volume on Complications after Thoracic Surgery. Anesthesiology. 2016;124(6):1286-1295. doi:10.1097/ALN.0000000000001100



BACKGROUND

The use of lung-protective ventilation (LPV) strategies may minimize iatrogenic lung injury in surgical patients. However, the identification of an ideal LPV strategy, particularly during one-lung ventilation (OLV), remains elusive. This study examines the role of ventilator management during OLV and its impact on clinical outcomes.

METHODS

Data were retrospectively collected from the hospital electronic medical record and the Society of Thoracic Surgery database for subjects undergoing thoracic surgery with OLV between 2012 and 2014. Mean tidal volume (VT) during two-lung ventilation and OLV and ventilator driving pressure (ΔP) (plateau pressure - positive end-expiratory pressure [PEEP]) were analyzed for the 1,019 cases that met the inclusion criteria. Associations between ventilator parameters and clinical outcomes were examined by multivariate linear regression.

RESULTS

After the initiation of OLV, 73.3, 43.3, 18.8, and 7.2% of patients received VT greater than 5, 6, 7, and 8 ml/kg predicted body weight, respectively. One hundred and eighty-four primary and 288 secondary outcome events were recorded. In multivariate logistic regression modeling, VT was inversely related to the incidence of respiratory complications (odds ratio, 0.837; 95% CI, 0.729 to 0.958), while ΔP predicted the development of major morbidity when modeled with VT (odds ratio, 1.034; 95% CI, 1.001 to 1.068).

CONCLUSIONS

Low VT per se (i.e., in the absence of sufficient PEEP) has not been unambiguously demonstrated to be beneficial. The authors found that a large proportion of patients continue to receive high VT during OLV and that VT was inversely related to the incidence of respiratory complications and major postoperative morbidity. While low (physiologically appropriate) VT is an important component of an LPV strategy for surgical patients during OLV, current evidence suggests that, without adequate PEEP, low VT does not prevent postoperative respiratory complications. Thus, use of physiologic VT may represent a necessary, but not independently sufficient, component of LPV.

Do Low Tidal Volumes Decrease Lung Injury During One-Lung Ventilation?

Slinger PD. Do Low Tidal Volumes Decrease Lung Injury During One-Lung Ventilation?. J Cardiothorac Vasc Anesth. 2017;31(5):1774-1775. doi:10.1053/j.jvca.2017.07.005

Low intraoperative tidal volume ventilation with minimal PEEP is associated with increased mortality.

Levin MA, McCormick PJ, Lin HM, Hosseinian L, Fischer GW. Low intraoperative tidal volume ventilation with minimal PEEP is associated with increased mortality. Br J Anaesth. 2014;113(1):97-108. doi:10.1093/bja/aeu054



BACKGROUND

Anaesthetists have traditionally ventilated patients' lungs with tidal volumes (TVs) between 10 and 15 ml kg(-1) of ideal body weight (IBW), without the use of PEEP. Over the past decade, influenced by the results of the Acute Respiratory Distress Syndrome Network trial, many anaesthetists have begun using lower TVs during surgery. It is unclear whether the benefits of low TV ventilation can be extended into the perioperative period.

METHODS

We reviewed the records of 29 343 patients who underwent general anaesthesia with mechanical ventilation between January 1, 2008 and December 31, 2011. We calculated TV kg(-1) IBW, PEEP, peak inspiratory pressure (PIP), and dynamic compliance. Cox regression analysis with propensity score matching was performed to examine the association between TV and 30-day mortality.

RESULTS

Median TV was 8.6 [7.7-9.6] ml kg(-1) IBW with minimal PEEP [4.0 (2.2-5.0) cm H2O]. A significant reduction in TV occurred over the study period, from 9 ml kg(-1) IBW in 2008 to 8.3 ml kg(-1) IBW in 2011 (P=0.01). Low TV 6-8 ml kg(-1) IBW was associated with a significant increase in 30-day mortality vs TV 8-10 ml kg(-1) IBW: hazard ratio (HR) 1.6 [95% confidence interval (CI) [1.25-2.08], P=0.0002]. The association remained significant after matching: HR 1.63 [95% CI (1.22-2.18), P<0.001]. There was only a weak correlation between TV kg(-1) IBW and dynamic compliance (r=-0.006, P=0.31) and a weak-to-moderate correlation between TV kg(-1) IBW and PIP (r=0.32 P<0.0001).

CONCLUSIONS

Use of low intraoperative TV with minimal PEEP is associated with an increased risk of 30-day mortality.

Pulmonary atelectasis: a pathogenic perioperative entity.

Duggan M, Kavanagh BP. Pulmonary atelectasis: a pathogenic perioperative entity. Anesthesiology. 2005;102(4):838-854. doi:10.1097/00000542-200504000-00021

Atelectasis occurs in the dependent parts of the lungs of most patients who are anesthetized. Development of atelectasis is associated with decreased lung compliance, impairment of oxygenation, increased pulmonary vascular resistance, and development of lung injury. The adverse effects of atelectasis persist into the postoperative period and can impact patient recovery. This review article focuses on the causes, nature, and diagnosis of atelectasis. The authors discuss the effects and implications of atelectasis in the perioperative period and illustrate how preventive measures may impact outcome. In addition, they examine the impact of atelectasis and its prevention in acute lung injury.

Impact of intraoperative lung-protective interventions in patients undergoing lung cancer surgery.

Licker M, Diaper J, Villiger Y, et al. Impact of intraoperative lung-protective interventions in patients undergoing lung cancer surgery. Crit Care. 2009;13(2):R41. doi:10.1186/cc7762



INTRODUCTION

In lung cancer surgery, large tidal volume and elevated inspiratory pressure are known risk factors of acute lung (ALI). Mechanical ventilation with low tidal volume has been shown to attenuate lung injuries in critically ill patients. In the current study, we assessed the impact of a protective lung ventilation (PLV) protocol in patients undergoing lung cancer resection.

METHODS

We performed a secondary analysis of an observational cohort. Demographic, surgical, clinical and outcome data were prospectively collected over a 10-year period. The PLV protocol consisted of small tidal volume, limiting maximal pressure ventilation and adding end-expiratory positive pressure along with recruitment maneuvers. Multivariate analysis with logistic regression was performed and data were compared before and after implementation of the PLV protocol: from 1998 to 2003 (historical group, n = 533) and from 2003 to 2008 (protocol group, n = 558).

RESULTS

Baseline patient characteristics were similar in the two cohorts, except for a higher cardiovascular risk profile in the intervention group. During one-lung ventilation, protocol-managed patients had lower tidal volume (5.3 +/- 1.1 vs. 7.1 +/- 1.2 ml/kg in historical controls, P = 0.013) and higher dynamic compliance (45 +/- 8 vs. 32 +/- 7 ml/cmH2O, P = 0.011). After implementing PLV, there was a decreased incidence of acute lung injury (from 3.7% to 0.9%, P < 0.01) and atelectasis (from 8.8 to 5.0, P = 0.018), fewer admissions to the intensive care unit (from 9.4% vs. 2.5%, P < 0.001) and shorter hospital stay (from 14.5 +/- 3.3 vs. 11.8 +/- 4.1, P < 0.01). When adjusted for baseline characteristics, implementation of the open-lung protocol was associated with a reduced risk of acute lung injury (adjusted odds ratio of 0.34 with 95% confidence interval of 0.23 to 0.75; P = 0.002).

CONCLUSIONS

Implementing an intraoperative PLV protocol in patients undergoing lung cancer resection was associated with improved postoperative respiratory outcomes as evidence by significantly reduced incidences of acute lung injury and atelectasis along with reduced utilization of intensive care unit resources.

Driving Pressure during Thoracic Surgery: A Randomized Clinical Trial.

Park M, Ahn HJ, Kim JA, et al. Driving Pressure during Thoracic Surgery: A Randomized Clinical Trial. Anesthesiology. 2019;130(3):385-393. doi:10.1097/ALN.0000000000002600



WHAT WE ALREADY KNOW ABOUT THIS TOPIC

Driving pressure (plateau minus end-expiratory airway pressure) is a target in patients with acute respiratory distress syndrome, and is proposed as a target during general anesthesia for patients with normal lungs. It has not been reported for thoracic anesthesia where isolated, inflated lungs may be especially at risk.

WHAT THIS ARTICLE TELLS US THAT IS NEW

In a double-blinded, randomized trial (292 patients), minimized driving pressure compared with standard protective ventilation was associated with less postoperative pneumonia or acute respiratory distress syndrome.

BACKGROUND

Recently, several retrospective studies have suggested that pulmonary complication is related with driving pressure more than any other ventilatory parameter. Thus, the authors compared driving pressure-guided ventilation with conventional protective ventilation in thoracic surgery, where lung protection is of the utmost importance. The authors hypothesized that driving pressure-guided ventilation decreases postoperative pulmonary complications more than conventional protective ventilation.

METHODS

In this double-blind, randomized, controlled study, 292 patients scheduled for elective thoracic surgery were included in the analysis. The protective ventilation group (n = 147) received conventional protective ventilation during one-lung ventilation: tidal volume 6 ml/kg of ideal body weight, positive end-expiratory pressure (PEEP) 5 cm H2O, and recruitment maneuver. The driving pressure group (n = 145) received the same tidal volume and recruitment, but with individualized PEEP which produces the lowest driving pressure (plateau pressure-PEEP) during one-lung ventilation. The primary outcome was postoperative pulmonary complications based on the Melbourne Group Scale (at least 4) until postoperative day 3.

RESULTS

Melbourne Group Scale of at least 4 occurred in 8 of 145 patients (5.5%) in the driving pressure group, as compared with 18 of 147 (12.2%) in the protective ventilation group (P = 0.047, odds ratio 0.42; 95% CI, 0.18 to 0.99). The number of patients who developed pneumonia or acute respiratory distress syndrome was less in the driving pressure group than in the protective ventilation group (10/145 [6.9%] vs. 22/147 [15.0%], P = 0.028, odds ratio 0.42; 95% CI, 0.19 to 0.92).

CONCLUSIONS

Application of driving pressure-guided ventilation during one-lung ventilation was associated with a lower incidence of postoperative pulmonary complications compared with conventional protective ventilation in thoracic surgery.

The Society for Translational Medicine: clinical practice guidelines for mechanical ventilation management for patients undergoing lobectomy.

Gao S, Zhang Z, Brunelli A, et al. The Society for Translational Medicine: clinical practice guidelines for mechanical ventilation management for patients undergoing lobectomy. J Thorac Dis. 2017;9(9):3246-3254. doi:10.21037/jtd.2017.08.166

Patients undergoing lobectomy are at significantly increased risk of lung injury. One-lung ventilation is the most commonly used technique to maintain ventilation and oxygenation during the operation. It is a challenge to choose an appropriate mechanical ventilation strategy to minimize the lung injury and other adverse clinical outcomes. In order to understand the available evidence, a systematic review was conducted including the following topics: (I) protective ventilation (PV); (II) mode of mechanical ventilation [e.g., volume controlled (VCV) versus pressure controlled (PCV)]; (III) use of therapeutic hypercapnia; (IV) use of alveolar recruitment (open-lung) strategy; (V) pre-and post-operative application of positive end expiratory pressure (PEEP); (VI) Inspired Oxygen concentration; (VII) Non-intubated thoracoscopic lobectomy; and (VIII) adjuvant pharmacologic options. The recommendations of class II are non-intubated thoracoscopic lobectomy may be an alternative to conventional one-lung ventilation in selected patients. The recommendations of class IIa are: (I) Therapeutic hypercapnia to maintain a partial pressure of carbon dioxide at 50-70 mmHg is reasonable for patients undergoing pulmonary lobectomy with one-lung ventilation; (II) PV with a tidal volume of 6 mL/kg and PEEP of 5 cmH2O are reasonable methods, based on current evidence; (III) alveolar recruitment [open lung ventilation (OLV)] may be beneficial in patients undergoing lobectomy with one-lung ventilation; (IV) PCV is recommended over VCV for patients undergoing lung resection; (V) pre- and post-operative CPAP can improve short-term oxygenation in patients undergoing lobectomy with one-lung ventilation; (VI) controlled mechanical ventilation with I:E ratio of 1:1 is reasonable in patients undergoing one-lung ventilation; (VII) use of lowest inspired oxygen concentration to maintain satisfactory arterial oxygen saturation is reasonable based on physiologic principles; (VIII) Adjuvant drugs such as nebulized budesonide, intravenous sivelestat and ulinastatin are reasonable and can be used to attenuate inflammatory response.

Adaptive lung ventilation (ALV) during anesthesia for pulmonary surgery: automatic response to transitions to and from one-lung ventilation.

Weiler N, Eberle B, Heinrichs W. Adaptive lung ventilation (ALV) during anesthesia for pulmonary surgery: automatic response to transitions to and from one-lung ventilation. J Clin Monit Comput. 1998;14(4):245-252. doi:10.1023/a:1009974825237



UNLABELLED

Adaptive lung ventilation is a novel closed-loop-controlled ventilation system. Based upon instantaneous breath-to-breath analyses, the ALV controller adjusts ventilation patterns automatically to momentary respiratory mechanics. Its goal is to provide a preset alveolar ventilation (V'A) and, at the same time, minimize the work of breathing. Aims of our study were (1) to investigate changes in respiratory mechanics during transition to and from one-lung ventilation (OLV), (2) to describe the automated adaptation of the ventilatory pattern.

METHODS

With institutional approval and informed consent, 9 patients (33-72 y, 66-88 kg) underwent ALV during total intravenous anesthesia for pulmonary surgery. The ALV controller uses a pressure controlled ventilation mode. V'A is preset by the anesthesiologist. Flow, pressure, and CO2 are continuously measured at the DLT connector. The signals were read into a IBM compatible PC and processed using a linear one-compartment model of the lung to calculate breath-by-breath resistance (R), compliance (C), respiratory time constant (TC), serial dead space (VdS) and V'A. Based upon the results, the controller optimizes respiratory rate (RR) and tidal volume (VT) such as to achieve the preset V'A with the minimum work of breathing. In addition to V'A, only PEEP and FIO2 settings are at the anesthesiologist's discretion. All patients were ventilated using FIO2 = 1,0 and PEEP = 3 cm H2O. Parameters of respiratory mechanics, ventilation, and ABG were recorded during three 5-min periods: 10 min prior to OLV (1), 20 min after onset of OLV (II), and after chest closure (III). Data analyses used nonparametric comparisons of paired samples (Wilcoxon, Friedman) with Bonferroni's correction. Significance was assumed at p < 0.05. Values are given as medians (range).

RESULTS

20 min after onset of OLV (II), resistance had approximately doubled compared with (1), compliance had decreased from 54 (36-81) to 50 (25-70) ml/cm H2O. TC remained stable at 1.4 (0.8-2.4) vs. 1.2 (0.9)-1.6) s. Institution of OLV was followed by a reproducible response of the ALV controller. The sudden changes in respiratory mechanics caused a transient reduction in VT by 42 (8-59)%, with RR unaffected. In order to reestablish the preset V'A, the controller increased inspiratory pressure in a stepwise fashion from 18 (14-23) to 27 (19-39) cm H2O, thereby increasing VT close to baseline (7.5 (6.6-9.0) ml/kg BW vs. 7.9 (5.4-11.7) ml/kg BW). The controller was, thus, effective in maintaining V'A. The minimum PaO2 during phase II was 101 mmHg. After chest closure, respiratory mechanics had returned to baseline.

CONCLUSIONS

Respiratory mechanics during transition to and from OLV are characterized by marked changes in R and C into opposite directions, leaving TC unaffected. The ALV controller manages these transitions successfully, and maintains V'A reliably without intervention by the anesthesiologist. VT during OLV was found to be consistently lower than recommended in the literature.